Emerging Paradigms in Delivery of Therapeutic Agents for the Treatment of Glioblastoma describes the intense research and clinical developments that are required to optimize the available treatment options and the potential side effects to heal brain cancer. The success of this strategy includes the use of validated biomarkers, appropriate patient selection criteria, strategies to prevent adverse events, and the implementation of immunotherapy in multimodal treatment approach. In 18 chapters, this title sets forth the rationales for promising therapies like immunotherapy, including immune checkpoint blockade, chimeric antigen receptor T (CAR T) cell therapy, oncolytic virotherapy, and vaccine therapy.

In addition, the book reviews potential novel agents, the current status of preclinical and clinical trials, and the challenges and future perspectives in glioblastoma immuno-oncology. This book is a valuable resource for health professionals, scientists and researchers, health practitioners, students, and all those who wish to broaden their knowledge in the allied field.

• Helps to design and develop nanocarrier drug delivery systems and devices for the treatment of glioblastoma
• Explores a wide range of promising approaches for the diagnosis and treatment of glioblastoma using the latest advancement in cutting-edge nanomedical technologies
• Covers recent advances and perspectives of novel drug delivery-based concepts for brain cancer research
• Includes recent patents and clinical trials in glioblastoma research, which will help fill in the gap between industries and academia